Case Study

Signant SmartSignals Unifed Platform Serves As An eSource For A COVID Treatment Trial

GettyImages-1305685152 vaccine

An emerging biopharmaceutical company utilized multiple solutions with Signant SmartSignals Unified Platform to conduct a phase II trial of a COVID treatment in critically ill patients, optimizing technology to meet the unique challenges of the trial and population.

See how the fully integrated platform was implemented two weeks faster than the proposed timeline, while taking into account all the study needs, including eSource data capture.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Hydrocarbon Online? Subscribe today.

Subscribe to Hydrocarbon Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Hydrocarbon Online